Abstract:

COVID-19 vaccines play a crucial role in reducing illness and death caused by SARS-CoV-2 infection. Despite their availability, disparities in vaccine uptake persist among low-income earners in Nigeria. Community organizations are vital in spreading essential vaccine information, understanding reasons for vaccine hesitancy, and promoting vaccine acceptance among the communities they serve. This study aimed to assess perceptions of COVID-19 vaccines among low-income communities in Oshodi/Isolo Local Government Area, Lagos State, Nigeria. Using a descriptive cross-sectional study design, data were collected from consenting adults via structured questionnaires with closed-ended questions. A total of 651 respondents participated, with the majority from Ejigbo (36.1%), followed by Isolo (33.9%), and Oshodi (30.0%). Most respondents were aged 18-45 years, and nearly equal numbers of males and females participated. Respondents' perceptions of COVID-19 vaccines were assessed through eight questions. Overall, perceptions were positive, with Ejigbo showing slightly higher perception scores compared to Isolo and Oshodi. Trust in the scientists who developed these vaccines likely contributed to this positive perception. While citizens were willing to receive COVID-19 vaccines, distrust in government programs and religious beliefs could hinder vaccination efforts. Targeted educational initiatives are necessary to address misconceptions, particularly in communities where religious beliefs strongly influence health decisions. Rebuilding trust between the government and citizens is crucial for achieving higher vaccination rates against COVID-19.

References:

[1] Pal M., Berhanu G., Desalegn C., Kandi V., 2020, Severe acute respiratory syndrome Coronavirus-2 (SARS-CoV 2): an update. Cureus. https://doi.org/10.7759/cureus.7423.

[2] Cucinotta D., Vanelli M., 2020, WHO declares COVID-19 a pandemic. Acta biomedical Atenei Parm, 91: 157–60.

[3] World Health Organization, 2021, WHO Coronavirus Disease (COVID-19) Dashboard, https://covid19.who.int/?gclid=EAIaIQobChMI2p622Oe6wIVxJrVCh0DJgDvEAAYASAAEgIeFfD_BwE.

[4] World Health Organization (WHO), 2022,WHO Coronavirus (COVID-19) Dashboard.

[5] NCDC. COVID-19 NIGERIA. Accessed 7th January 2022.

[6] World Population Review. Nigeria Population 2022 (Live). Accessed 7th January 2022

[7] NPHCDA. Welcome Message from the ED/CEO. Accessed 7th January 2022.

[8] Our World in Data, 2022, Coronavirus Pandemic (COVID-19). Accessed 7th January 2022.

[9] Wang J, Jing R, Lai X, Zhang H, Lyu Y, Knoll MD et al., 2022, Acceptance of COVID-19 Vaccination during the COVID-19 Pandemic in China. Vaccines (Basel), 8(3), 482.

[10] World Health Organization (WHO)., 2020 Behavioural considerations for acceptance and uptake of COVID-19 vaccines: WHO technical advisory group on behavioural insights and sciences for health, meeting report, 15 October. Accessed 7th January 2022.

[11] MacDonald N. E., 2015, Vaccine hesitancy: Definition, scope and determinants. Vaccine. 33(34), 4161-4164.

[12] Larson H. J., Jarrett C., Eckersberger E., Smith D. M. D., 2014, Paterson P. Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: A systematic review of published literature, 2007-2012. Vaccine. 32(19),a 2150-2159.

[13] Wang J., Jing R., Lai X., Zhang H., Lyu Y., Knoll M. D. et al., 2020, Acceptance of COVID-19 Vaccination during the COVID-19 Pandemic in China. Vaccines (Basel). 8(3), 482.

[14] Ferdous M. Z., Islam M. S., Sikder M. T., Mosaddek A. S. M., Zegarra-Valdivia J. A., Gozal D., 2020, Knowledge, attitude, and practice regarding COVID-19 outbreak in Bangladesh: an online-based cross-sectional study. PLoS One. 15(10), e0239254. https://doi.org/10.1371/journal.pone.0239254.

[15] Graffigna G., Palamenghi L., Boccia S., Barello S., 2020, Relationship between Citizens´ Health Engagement and Intention to Take the COVID-19 Vaccine in Italy: A Mediation Analysis. Vaccines (Basel). 8(4), 576.

[16] Pogue K., Jensen J. L., Stancil C. K., Ferguson D. G., Hughes S. J., Mello E. J. et al., 2020, Influences on Attitudes Regarding Potential COVID-19 Vaccination in the United States. Vaccines (Basel). 8(4), 582.

[17] Head K. J., Kasting M. L., Sturm L. A., Hartsock J. A., Zimet G. D., 2020, A National Survey Assessing SARSCoV-2 Vaccination Intentions: Implications for Future Public Health Communication Efforts. Science Communication. 42(5), 698-723.

[18] Sherman S. M., Smith L. E., Sim J., Amlôt R., Cutts M., Dasch H. et al., 2021, COVID-19 vaccination intention in the UK: results from the COVID-19 vaccination acceptability study (CoVAccS), a nationally representative cross-sectional survey. Hum Vaccin Immunother. 17 (6), 1612-1621.

[19] Reiter P. L., Pennell M. L., Katz M. L., 2020 Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated? Vaccine. 38(42), 6500-6507.

[20] Biasio L. R., Bonaccorsi G., Lorini C., Pecorelli S., 2021, Assessing COVID-19 vaccine literacy: a preliminary online survey. Hum Vaccin Immunother. 17 (5), 1304-1312.

[21] Eastwood K., Durrheim D. N., Jones A., Butler M., 2010, Acceptance of pandemic (H1N1) 2009 influenza vaccination by the Australian public. Med J Aust. 192 (1): 33-36.

[22] Bruce N., et al., 2008, Quantitative research methods for health research: a practical interactive guide to epidemiology and statistics. Chichester, UK: Wiley

[23] CSPro (2023) Census and Survey Processing System (CSPro) Online Available https://www.census.gov/data/software/cspro.html (Accessed July 2023)

[24] Banik R., Rahman M., Sikder M. T., Rahman Q. M., Pranta M. U. R., 2021, Knowledge, attitudes, and practices related to the COVID-19 pandemic among Bangladeshi youth: a web-based cross-sectional analysis. J Public Health (Bangkok). https://doi.org/10.1007/s10389-020-01432-7.

[25] Hossain M. A., Jahid M. I. K., Hossain K. M. A, Walton L. M., Uddin Z., Haque M. O., et al., 2020, Knowledge, attitudes, and fear of COVID-19 during the rapid rise period in Bangladesh. PLoS One. 15(9), e0239646. https://doi.org/10.1371/journal.pone.0239646